DRIP Investor

The DRIP Investor is a monthly newsletter dedicated to educating individual investors about the huge profit opportunities offered by Dividend Reinvestment Plans (DRIPs). Long-term investors who understand the power every dollar invested can have on a portfolio will find DRIP Investor to be invaluable...
Read More

From the Conference Floor

This year’s get-together has been particularly lively, as the Cabot analysts present a rich mix of market analysis, investing techniques, stock picks and answers to probing questions from both new attendees and veterans of previous conferences.
Read More

Novo Nordisk (NVO)

This big pharma company just received an FDA panel recommendation for its obesity drug. The shares have a current dividend yield of 1.3%, paid annually. Novo Nordisk (NVO) from DRIP Investor It is extremely easy for any U.S. investor to buy individual foreign stocks via American Receipts...
Read More

Selling Your DRIPs

From The DRIP Investor Most Dividend Reinvestment Plans (DRIPs) have expanded the ways in which participants can sell their shares, from sending a transaction request form via the postal service to telephoning sale orders or even going online to sell shares. Investors also the...
Read More

Nucor (NUE)

Vita Nelson’s DirectInvesting.com offers a wealth of information on dividend reinvestment plans, or DRIPs, and other direct investing options. Below is a quick review of their current “$20 Special Stock” (the discounted DRIP enrollment fee for members), a reliable dividend payer appropriate for income...
Read More

Bemis Company, Inc. (BMS)

Today's brief recommendation is a dividend aristocrat from Vita Nelson's DirectInvesting.com, a comprehensive source of information on DRIPs (dividend reinvestment plans) and other direct investing plans. "Bemis Company, Inc. (BMS, $31) -- Founded in 1858 as the Bemis Brothers Bag Company, this is a major manufacturer flexible...
Read More